$6.8M Investment Pushes Pronota Closer To Development of Diagnostics Pipeline
July 09, 2009
$6.8M Investment Pushes Pronota Closer To Development of Diagnostics Pipeline
The Belgian firm will use the funds, secured in the first close of its Series B financing, for the further development of diagnostic programs underway for acute heart failure, sepsis, preeclampsia, and ovarian cancer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Movers & Shakers
August 26, 2011 / ProteoMonitor - Some Proteomics Firms Exploring Next-Generation Sequencing for Biomarker Research
May 6, 2011 / ProteoMonitor - Pronota Signs Agreement with Molecuence to Develop Protein Biomarkers for Stroke
February 25, 2011 / ProteoMonitor - Pronota Raises Additional $1.8M in Financing
May 18, 2010 / GenomeWeb Daily News - Pronota Receives $2M to Further Development of Cardiovascular Biomarkers
January 15, 2010 / ProteoMonitor